Thursday, November 19, 2026

Subscribe

NewsEdition DR CongoDR Congo

DR Congo: Ebola spreads to Bas-Uélé as PARTNERS trial reaches 100 patients

Bas-Uélé becomes the sixth province affected by the Ebola outbreak in DR Congo, where cases and deaths continue to rise. In Bunia, the PARTNERS trial of treatments for Bundibugyo virus reaches 100 participants.

Journalists in a newsroom in Kinshasa prepare an Ebola update in front of screens and cameras.

When the virus moves faster than response teams

In the east and north-east of the Democratic Republic of the Congo, Ebola is no longer confined to a single isolated outbreak. The virus has crossed a new administrative boundary, with a death recorded in Bas-Uélé, a province that had previously been spared, bringing the number of affected provinces to six. In an outbreak moving this fast, every new area affected makes surveillance, case isolation and the protection of families more difficult.

This spread comes as the country’s health response is already operating in difficult terrain. The disease is circulating in several provinces, with its centre of gravity still in Ituri, but also with outbreaks in Haut-Uélé, North Kivu, South Kivu, Tshopo and now Bas-Uélé. Congolese health authorities, the African Union’s Africa CDC and the WHO describe an outbreak that remains active, fuelled by population movements, hard-to-reach areas and interruptions in access to healthcare.

Bas-Uélé: another warning as the outbreak map widens

The new case reported in Bas-Uélé involved a person who died after travelling from Haut-Uélé, according to Jean Kaseya, director-general of Africa CDC. This detail matters because it shows that the virus is not circulating only in the villages initially affected. It is also following everyday travel routes, commercial ties and family journeys between neighbouring provinces.

As of 15 July 2026, the WHO reported 2,124 confirmed cases and 828 deaths in DR Congo, across 46 health zones in five provinces. The organisation also said that 12,693 contacts had been identified and monitored, including 119 confirmed cases among health workers. These figures have continued to change since then, explaining the growing alarm among those working on the ground.

Bas-Uélé is not at the geographical centre of this outbreak, but its inclusion on the list of affected provinces changes the scale of the problem. It adds a logistical burden to an already stretched response, as alerts, sample collection, patient transfers and community communications must now be strengthened across an even wider area. In a crisis like this, geography becomes a medical factor in its own right.

Clinical research moves forward, without rushing to promise results

Alongside the emergency response, research is advancing on another front. In Bunia, the PARTNERS clinical trial has begun recruiting patients to assess two potential treatments for Ebola virus disease caused by Bundibugyo virus: MBP134, a monoclonal antibody, and remdesivir, an antiviral already used in other settings. The WHO confirmed the trial’s launch on 2 July 2026 and said the programme is being conducted with the Congolese INRB, the Institute of Tropical Medicine in Antwerp and the University of Oxford, with support from Africa CDC.

The latest milestone, reported by the WHO and scientific partners, is that the trial has reached 100 participants. This does not mean that a treatment has been approved. It simply indicates that the study is growing and now has a stronger basis for comparing patient groups. The protocol tests the drugs separately and then in combination to determine whether either actually improves survival.

Launching a trial during an outbreak is no trivial matter. It reflects a simple idea, often repeated by African and international researchers: waiting until an outbreak is over to produce scientific evidence can sometimes mean arriving too late. Here, DR Congo is not merely a place where an intervention is carried out. It is also becoming a site for producing knowledge that can be used in future outbreaks of filoviruses, the viruses responsible for Ebola and related diseases.

What this means for Congolese people and health services

For residents, the questions remain immediate: where to get tested, how to avoid infection and how far away the nearest centre able to take suspected cases is. In Bunia, MSF teams have expanded the Elikya centre, while other partner facilities have had to adapt their capacity. This organisation is crucial, because the earlier a diagnosis is made, the sooner the chain of transmission can be broken.

For health workers, the risk remains high. The WHO reports persistent infections among health workers, an indicator that reveals both the intensity of transmission and shortcomings in infection prevention and control. This points to concrete realities: inadequate equipment, overcrowded facilities, difficult travel and care sometimes provided in precarious conditions.

For the authorities, the challenge goes beyond managing a single outbreak. They must coordinate local, provincial and national levels while working with the WHO, Africa CDC and humanitarian partners. In a country the size of a continent like DR Congo, where distances are long and infrastructure uneven, the Ebola response requires a rapid chain of decision-making, as well as strong community acceptance. Without the communities’ trust, contact tracing becomes less effective and alerts come too late.

An alert for DR Congo, but also a test for the region

The crisis extends beyond Congo’s borders. Bas-Uélé is close to the Central African Republic, while other affected provinces border Uganda or lie along routes towards East Africa. The WHO has already classified the Bundibugyo outbreak as a public health emergency of international concern, placing DR Congo at the centre of heightened regional vigilance.

This situation also highlights a reality that is often underestimated: the most effective responses to Ebola are neither purely medical nor solely security-focused. They combine surveillance, care, communication, logistics and research. DR Congo thus shows two sides: a country heavily exposed to health crises, but also a place where institutions such as the INRB, organisations such as MSF, and African and international partners are developing scientific responses in real time.

For Central Africa, the challenge is clear: contain the outbreak before it brings more restrictions, more fear and further loss of life. For the continent, another message is equally clear: the ability to launch clinical trials in the midst of a crisis is becoming a measure of health sovereignty. An important part of Africa’s response to emerging epidemics is now being shaped on this front.

Automatic translation. Original French version

News quiz

Edition DR CongoDR Congo: the news quiz for 14–15 November

5 questions